Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humboldt Seed Organization (HSO) is a prominent cannabis breeding and biotechnology company that specializes in the development, stabilization, and distribution of elite cannabis genetics. Originally rooted in the Emerald Triangle of Northern California, the company established a significant European presence to facilitate global distribution and advanced research into cannabinoid profiles. HSO focuses on high-quality seed production, including feminized, autoflowering, and fast-flowering varieties, tailored for both medicinal and recreational use. Their work emphasizes the optimization of terpene and cannabinoid content, contributing to the standardization of strains used in therapeutic applications worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Humboldt Seeds Europe.